Canada Life’s Principia Biopharma Inc. Common Stock PRNB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
– Sell
-1,522
Closed -$90K – 2750
2020
Q2
$90K Hold
1,522
– – ﹤0.01% 2074
2020
Q1
$90K Hold
1,522
– – ﹤0.01% 2004
2019
Q4
$83K Buy
+1,522
New +$56.8K ﹤0.01% 2118
2019
Q3
– Sell
-889
Closed -$30K – 2637
2019
Q2
$30K Buy
+889
New +$27.8K ﹤0.01% 2541

Other funds holding PRNB

Canada Life's PRNB Position: Q3 2020 in Review

Canada Life sold out of Principia Biopharma Inc. Common Stock (PRNB) in Q3 2020, closing a stake of 1,522 shares — an estimated $90K sold.

Canada Life first reported a position in PRNB in Q2 2019 and held it in 4 quarters. The position peaked at $90K in Q2 2020. 9 funds tracked by Wall St. Rank hold PRNB as of Q3 2020.

  • Canada Life reported no remaining Principia Biopharma Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • Canada Life sold 1,522 Principia Biopharma Inc. Common Stock shares in Q3 2020, an estimated $90K.
  • Canada Life first reported a position in Principia Biopharma Inc. Common Stock in Q2 2019 and held it in 4 quarters.
  • Canada Life's Principia Biopharma Inc. Common Stock position peaked at $90K in Q2 2020.
  • 9 funds tracked by Wall St. Rank held Principia Biopharma Inc. Common Stock as of Q3 2020.

Based on Canada Life's 13F filing for Q3 2020, filed 13 Nov 2020.